TYK2 : p.Pro1104Ala Variant Protects Against Autoimmunity by Modulating Immune Cell Levels
Immunology · 2025
DOI: 10.1111/imm.13902 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, 2025. Verfasst von Maristella Steri und 23 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Genetic and Biomedical Research (IRGB), Italian National Research Council (CNR), Monserrato, Sardinia, Italy. Hauptthemen laut MEDLINE: TYK2 Kinase, Autoimmunity, Autoimmune Diseases, B-Lymphocytes. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, Fondazione Italiana Sclerosi Multipla (FISM), financed or co-financed with the '5 per mille' public funding.
Abstract (Originalsprache)
The TYK2 :p.Pro1104Ala (rs34536443) hypomorph variant has been associated with protection against numerous autoimmune disorders. Thus, its mechanism of action becomes of great interest. Here, consistent with the participation of activated immune cells in autoimmunity, we show that the variant regulates the levels of immune cells at a human, general population level and is associated particularly with higher levels of T and B lymphocytes, especially the naïve (non‐activated) compartment. Also, consistent with a protective function in autoimmunity, the level of regulatory CD4+ T cells was increased. Thus, this variant decreases immune activation thereby protecting from autoimmunity. Our work links the cellular mechanism regulated by the TYK2 :p.Pro1104Ala variant to autoimmunity protection and supports TYK2 as a therapeutic target in autoimmunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Genetic and Biomedical Research (IRGB), Italian National Research Council (CNR), Monserrato, Sardinia, Italy.
- Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
- Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy.
- Laboratory of Genetics and Genomics, National Institute on Aging (NIA), National Institutes of Health (NIH), Baltimore, Maryland, USA.
ORCID-Profile: Antonella Mulas, Magdalena Zoledziewska
Förderung
- NIDA NIH HHS
- Fondazione Italiana Sclerosi Multipla (FISM)
- financed or co-financed with the '5 per mille' public funding
Zitieren
APA
Steri, M., Orrù, V., Sidore, C., Mulas, A., Pitzalis, M., Busonero, F., Maschio, A., Serra, V., Dei, M., Lai, S., Virdis, F., Lobina, M., Loizedda, A., Marongiu, M., Masala, M., Floris, M., Curreli, N., Balaci, L., Loi, F., …, & Zoledziewska, M. (2025). TYK2 : p.Pro1104Ala Variant Protects Against Autoimmunity by Modulating Immune Cell Levels. Immunology. https://doi.org/10.1111/imm.13902
Vancouver
Steri M, Orrù V, Sidore C, Mulas A, Pitzalis M, Busonero F, et al. TYK2 : p.Pro1104Ala Variant Protects Against Autoimmunity by Modulating Immune Cell Levels. Immunology. 2025. doi:10.1111/imm.13902
BibTeX
@article{Steri2025,
author = {Steri, Maristella and Orrù, Valeria and Sidore, Carlo and Mulas, Antonella and Pitzalis, Maristella and Busonero, Fabio and Maschio, Andrea and Serra, Valentina and Dei, Mariano and Lai, Sandra and Virdis, Francesca and Lobina, Monia and Loizedda, Annalisa and Marongiu, Michele and Masala, Marco and Floris, Matteo and Curreli, Nicolò and Balaci, Lenuta and Loi, Francesco and Pilia, Maria Grazia and Delitala, Alessandro and Fiorillo, Edoardo and Schlessinger, David and Zoledziewska, Magdalena},
title = {TYK2 : p.Pro1104Ala Variant Protects Against Autoimmunity by Modulating Immune Cell Levels},
journal = {Immunology},
year = {2025},
doi = {10.1111/imm.13902}
}
EUVIMED